Next Article in Journal
Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine
Next Article in Special Issue
Selective Induction of Cancer Cell Death by Targeted Granzyme B
Previous Article in Journal
Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications
Previous Article in Special Issue
Dissecting the Entry Route of Saporin-based a-CD7 Immunotoxins in Human T-Cell Acute Lymphoblastic Leukaemia Cells
Review

An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells

1
Department of Pharmacology, University of Minnesota, 210 Delaware Street Southeast Minneapolis, MN 55455, USA
2
Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, 425 East River Parkway Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Antibodies 2013, 2(1), 82-92; https://doi.org/10.3390/antib2010082
Received: 6 December 2012 / Revised: 19 January 2013 / Accepted: 22 January 2013 / Published: 28 January 2013
(This article belongs to the Special Issue Recombinant Immunotoxins)
Targeting and killing specific cells discriminately has been the goal of targeted therapy dating back to the era of Paul Ehrlich. The discovery of cancer stem cells has caused a paradigm shift within the cancer field and provided an opportunity to use targeted therapies such as targeted toxins to bind and kill these cells selectively. A number of targeted toxins have been developed against recently identified cancer stem cell markers. In this review we discuss the development and current status of these exciting novel drugs and their potential use to combat drug-refractory relapse. View Full-Text
Keywords: cancer stem cells; targeted toxins; immunotoxins; CD133; EpCAM; CD123; CD44 cancer stem cells; targeted toxins; immunotoxins; CD133; EpCAM; CD123; CD44
MDPI and ACS Style

Waldron, N.N.; Vallera, D.A. An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. Antibodies 2013, 2, 82-92. https://doi.org/10.3390/antib2010082

AMA Style

Waldron NN, Vallera DA. An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. Antibodies. 2013; 2(1):82-92. https://doi.org/10.3390/antib2010082

Chicago/Turabian Style

Waldron, Nate N., and Daniel A. Vallera 2013. "An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells" Antibodies 2, no. 1: 82-92. https://doi.org/10.3390/antib2010082

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop